We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Donaldson Company, Inc. (DCI - Free Report) is poised to gain from solid momentum across its segments. The Mobile Solutions segment has been benefiting from higher volume in the aftermarket business, driven by healthy demand for replacement filters for both air and liquid filtration applications. The Industrial Solutions segment is driven by persistent strength in the aerospace and defense business. Robust momentum in the commercial aerospace and rotorcraft markets, as well as solid demand in defense markets due to the modernization of equipment and the impact of global conflicts, augurs well for the segment.
Strength in the bio-processing business, arising from an increase in lab-based applications and bio-reactor production, is boosting the Life Sciences segment. Solid momentum in the disk drive business is also aiding the segment.
The company believes in expanding its market presence, solidifying its customer base and enhancing product offerings through acquisitions. In August 2024, Donaldson completed the acquisition of a 49% minority stake in Medica S.p.A. The inclusion of Medica’s technology and expertise in filtration products will enable the company to penetrate new markets and diversify its offerings in the medical device and water purification sectors.
In June 2023, the company acquired Univercells Technologies, expanding its growing offering in the life sciences industry. Univercells will be added to Donaldson’s Life Sciences segment. The company acquired Isolere Bio in February 2023. The Isolere buyout enabled Donaldson to create leading separation and filtration solutions for emerging genetic-based drugs. Isolere’s revenues are reported within the Life Sciences segment.
Donaldson is committed to rewarding its shareholders handsomely through dividends and share buybacks. Dividend payments totaled $122.8 million in fiscal 2024. The company bought back shares worth $162.7 million in fiscal 2024. It is worth noting that its quarterly dividend was hiked 8% in May 2024. The company has raised its dividend for 28 consecutive years. In November 2023, its board of directors approved a new repurchase program, authorizing it to repurchase up to 12 million shares of its common stock. The new repurchase program replaced the previous one, which was approved in 2019.
In the past three months, this Zacks Rank #3 (Hold) company’s shares have gained 5.1% compared with the industry’s 0.7% growth.
Image Source: Zacks Investment Research
Headwinds Plaguing DCI
Donaldson has been witnessing weakness in the on-road and off-road businesses. Lower levels of equipment production owing to softness in industrial markets, particularly in the United States and China, are affecting the company's on-road business. Weakness in agriculture markets and soft end-market demand in China are upsetting the off-road business. Also, challenged market conditions in dust collection and power generation verticals within the industrial filtration solutions business remain concerning.
The company has been dealing with the adverse impacts of high selling, general and administrative expenses. Increasing headcount and incremental expenses associated with investments in acquired businesses are pushing up the selling, general and administrative expenses, which increased 5.7% to $636.7 million in fiscal 2024. The impact of these expenditures is evident in the rise of the selling, general and administrative expenses as a percentage of total revenues, which climbed 20 basis points to reach 17.8%. Also, the overall operating expenses increased 7.3% year over year to $730.3 million in fiscal 2024. The metric, as a percentage of total revenues, increased 60 basis points to 20.4%.
ATMU delivered a trailing four-quarter average earnings surprise of 13.8%. In the past 60 days, the Zacks Consensus Estimate for Atmus’ 2024 earnings increased 5.2%.
Tetra Tech, Inc. (TTEK - Free Report) presently carries a Zacks Rank of 2. The company delivered a trailing four-quarter average earnings surprise of 4.5%.
In the past 60 days, the Zacks Consensus Estimate for TTEK’s fiscal 2024 earnings has remained steady.
RBC Bearings Incorporated (RBC - Free Report) presently carries a Zacks Rank of 2. The company delivered a trailing four-quarter average earnings surprise of 2.5%.
In the past 60 days, the consensus estimate for RBC’s fiscal 2025 earnings has increased 1.4%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Donaldson Stock Exhibits Strong Prospects Despite Headwinds
Donaldson Company, Inc. (DCI - Free Report) is poised to gain from solid momentum across its segments. The Mobile Solutions segment has been benefiting from higher volume in the aftermarket business, driven by healthy demand for replacement filters for both air and liquid filtration applications. The Industrial Solutions segment is driven by persistent strength in the aerospace and defense business. Robust momentum in the commercial aerospace and rotorcraft markets, as well as solid demand in defense markets due to the modernization of equipment and the impact of global conflicts, augurs well for the segment.
Strength in the bio-processing business, arising from an increase in lab-based applications and bio-reactor production, is boosting the Life Sciences segment. Solid momentum in the disk drive business is also aiding the segment.
The company believes in expanding its market presence, solidifying its customer base and enhancing product offerings through acquisitions. In August 2024, Donaldson completed the acquisition of a 49% minority stake in Medica S.p.A. The inclusion of Medica’s technology and expertise in filtration products will enable the company to penetrate new markets and diversify its offerings in the medical device and water purification sectors.
In June 2023, the company acquired Univercells Technologies, expanding its growing offering in the life sciences industry. Univercells will be added to Donaldson’s Life Sciences segment. The company acquired Isolere Bio in February 2023. The Isolere buyout enabled Donaldson to create leading separation and filtration solutions for emerging genetic-based drugs. Isolere’s revenues are reported within the Life Sciences segment.
Donaldson is committed to rewarding its shareholders handsomely through dividends and share buybacks. Dividend payments totaled $122.8 million in fiscal 2024. The company bought back shares worth $162.7 million in fiscal 2024. It is worth noting that its quarterly dividend was hiked 8% in May 2024. The company has raised its dividend for 28 consecutive years. In November 2023, its board of directors approved a new repurchase program, authorizing it to repurchase up to 12 million shares of its common stock. The new repurchase program replaced the previous one, which was approved in 2019.
In the past three months, this Zacks Rank #3 (Hold) company’s shares have gained 5.1% compared with the industry’s 0.7% growth.
Image Source: Zacks Investment Research
Headwinds Plaguing DCI
Donaldson has been witnessing weakness in the on-road and off-road businesses. Lower levels of equipment production owing to softness in industrial markets, particularly in the United States and China, are affecting the company's on-road business. Weakness in agriculture markets and soft end-market demand in China are upsetting the off-road business. Also, challenged market conditions in dust collection and power generation verticals within the industrial filtration solutions business remain concerning.
The company has been dealing with the adverse impacts of high selling, general and administrative expenses. Increasing headcount and incremental expenses associated with investments in acquired businesses are pushing up the selling, general and administrative expenses, which increased 5.7% to $636.7 million in fiscal 2024. The impact of these expenditures is evident in the rise of the selling, general and administrative expenses as a percentage of total revenues, which climbed 20 basis points to reach 17.8%. Also, the overall operating expenses increased 7.3% year over year to $730.3 million in fiscal 2024. The metric, as a percentage of total revenues, increased 60 basis points to 20.4%.
Stocks to Consider
Some better-ranked companies are discussed below.
Atmus Filtration Technologies Inc. (ATMU - Free Report) currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
ATMU delivered a trailing four-quarter average earnings surprise of 13.8%. In the past 60 days, the Zacks Consensus Estimate for Atmus’ 2024 earnings increased 5.2%.
Tetra Tech, Inc. (TTEK - Free Report) presently carries a Zacks Rank of 2. The company delivered a trailing four-quarter average earnings surprise of 4.5%.
In the past 60 days, the Zacks Consensus Estimate for TTEK’s fiscal 2024 earnings has remained steady.
RBC Bearings Incorporated (RBC - Free Report) presently carries a Zacks Rank of 2. The company delivered a trailing four-quarter average earnings surprise of 2.5%.
In the past 60 days, the consensus estimate for RBC’s fiscal 2025 earnings has increased 1.4%.